|1.||Lin, Don S: 1 article (09/2005)|
|2.||Gerhard, Glenn: 1 article (09/2005)|
|3.||Pappu, Anuradha S: 1 article (09/2005)|
|4.||Frohlich, Jiri: 1 article (09/2005)|
|5.||Connor, William E: 1 article (09/2005)|
|6.||Cerny, R E: 1 article (01/2000)|
|7.||Clouse, S D: 1 article (01/2000)|
|8.||Koka, C V: 1 article (01/2000)|
|9.||Takatsuto, S: 1 article (01/2000)|
|10.||Noguchi, T: 1 article (01/2000)|
09/01/2005 - "Our data indicate that dietary sitostanol and campestanol are absorbed by patients with sitosterolemia and xanthomatosis and also by rats. "
09/01/2005 - "Dietary sitostanol and campestanol: accumulation in the blood of humans with sitosterolemia and xanthomatosis and in rat tissues."
02/01/1985 - "These results indicate that abnormally high plasma concentrations of cholestanol, 5 alpha-campestanol, and 5 alpha-sitostanol are found in subjects with sitosterolemia and xanthomatosis, and that treatment with cholestyramine effectively reduced elevated plasma sterol levels."
|3.||Body Weight (Weight, Body)
06/01/1998 - "To assess the short-term cholesterol-lowering potential of sitostanol-containing tall oil plant sterols, 22 subjects consumed fixed-food diets over two 10-day periods with or without 21.2 mg/kg body weight/d tall oil phytosterols (sitosterol 62%, sitostanol 21%, campesterol 16%, and campestanol 1%) in a randomized crossover study design. "
|4.||Phytosterols (Plant Sterols)
|6.||Cholestyramine Resin (Questran)